Share Price and Basic Stock Data
Last Updated: November 28, 2025, 9:46 am
| PEG Ratio | -0.61 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uflex Ltd, a prominent player in the Packaging & Containers industry, reported a market capitalization of ₹3,684 Cr and a current price of ₹510 per share. The company has shown a steady revenue trajectory, with total sales rising from ₹5,826 Cr in FY 2014 to ₹14,663 Cr in FY 2023, reflecting a compounded annual growth rate (CAGR) of approximately 13.52% over this period. However, in FY 2024, sales declined to ₹13,364 Cr, before recovering to ₹15,036 Cr in FY 2025. This fluctuation in revenue highlights the challenges faced by the company, particularly in the competitive packaging sector. Quarterly sales for June 2023 stood at ₹3,258 Cr, with a modest increase to ₹3,369 Cr in September 2023. Overall, the company’s revenue performance has been marked by volatility, necessitating strategic adjustments to stabilize and enhance growth.
Profitability and Efficiency Metrics
Uflex Ltd’s profitability metrics have exhibited significant fluctuations in recent quarters. The operating profit margin (OPM) fell from 18% in June 2022 to a low of 9% in June 2023, before stabilizing around 11% in subsequent quarters. The net profit for FY 2023 was reported at ₹481 Cr, a stark decline from ₹1,099 Cr in FY 2022, reflecting a challenging operational environment. The company recorded a net profit of ₹142 Cr in FY 2025, demonstrating a recovery. Efficiency ratios reveal a cash conversion cycle (CCC) of 101 days, indicating room for improvement in managing working capital. The interest coverage ratio (ICR) stood at 2.63x, suggesting that while the company can meet its interest obligations, it operates with a degree of financial leverage that could pose risks if earnings continue to fluctuate.
Balance Sheet Strength and Financial Ratios
Uflex Ltd’s balance sheet reflects a mix of strengths and weaknesses. As of FY 2025, total borrowings amounted to ₹8,353 Cr against reserves of ₹7,324 Cr, indicating a debt-to-equity ratio of 1.10x, which is higher than typical industry standards. The company reported a return on equity (ROE) of 3.29% and a return on capital employed (ROCE) of 7.75%, both of which are relatively low compared to sector norms. The book value per share stood at ₹1,023, while the price-to-book value ratio was reported at 0.48x, suggesting that Uflex Ltd’s shares are undervalued relative to its net assets. The current ratio of 1.31 indicates adequate liquidity, although the quick ratio of 0.91 suggests potential challenges in meeting short-term obligations without relying on inventory sales.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uflex Ltd showcases a diverse ownership structure, with promoters holding 44.58% of the company. Foreign institutional investors (FIIs) accounted for 7.75%, while domestic institutional investors (DIIs) held a mere 0.52%. Public shareholders comprised 47.16% of the total, with the number of shareholders increasing from 57,626 in December 2022 to 44,372 in September 2025. The gradual decline in the number of shareholders could indicate waning investor confidence, particularly as the company has faced significant profitability challenges. The decline in FIIs from 8.34% in December 2022 to 7.75% in March 2025 may further reflect cautious sentiment among institutional investors regarding the company’s future prospects.
Outlook, Risks, and Final Insight
The outlook for Uflex Ltd hinges on its ability to stabilize revenue and enhance profitability amidst a competitive landscape. Key strengths include its established market presence and potential for operational improvements. However, risks such as high debt levels, fluctuating profitability, and investor sentiment pose challenges. The company must focus on driving efficiency and managing costs to improve margins. Additionally, addressing working capital management could enhance its cash flow position. If Uflex can leverage its strengths effectively, it may achieve sustainable growth; however, failure to navigate these risks could hinder its recovery and long-term performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Uflex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 130 Cr. | 125 | 225/107 | 11.8 | 210 | 0.64 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 96.0 Cr. | 170 | 191/160 | 13.9 | 94.4 | 0.89 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 17.4 Cr. | 12.6 | 34.5/11.0 | 23.6 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 16.0 Cr. | 7.25 | 10.4/4.85 | 19.5 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 9,048 Cr. | 3,895 | 5,378/2,317 | 28.9 | 1,079 | 0.31 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 2,014.87 Cr | 348.08 | 49.49 | 189.19 | 0.32% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,032 | 3,768 | 3,483 | 3,380 | 3,258 | 3,369 | 3,309 | 3,426 | 3,654 | 3,833 | 3,735 | 3,814 | 3,901 |
| Expenses | 3,321 | 3,356 | 3,219 | 3,011 | 2,975 | 2,984 | 2,978 | 3,060 | 3,245 | 3,441 | 3,281 | 3,404 | 3,447 |
| Operating Profit | 711 | 412 | 264 | 370 | 284 | 386 | 332 | 366 | 408 | 392 | 454 | 410 | 454 |
| OPM % | 18% | 11% | 8% | 11% | 9% | 11% | 10% | 11% | 11% | 10% | 12% | 11% | 12% |
| Other Income | 14 | 81 | -70 | -52 | -362 | 20 | -64 | -319 | -149 | -73 | 65 | 132 | 21 |
| Interest | 105 | 105 | 133 | 130 | 135 | 132 | 140 | 128 | 162 | 178 | 174 | 184 | 199 |
| Depreciation | 144 | 146 | 144 | 166 | 160 | 164 | 166 | 165 | 173 | 173 | 172 | 176 | 187 |
| Profit before tax | 476 | 242 | -83 | 22 | -373 | 110 | -39 | -247 | -76 | -31 | 173 | 182 | 89 |
| Tax % | 21% | 21% | 3% | 96% | 12% | 42% | 72% | 10% | 30% | 108% | 21% | 7% | 35% |
| Net Profit | 375 | 191 | -85 | 1 | -416 | 63 | -67 | -271 | -98 | -65 | 137 | 169 | 58 |
| EPS in Rs | 51.86 | 26.41 | -11.83 | 0.12 | -57.63 | 8.77 | -9.31 | -37.51 | -13.63 | -8.95 | 18.95 | 23.34 | 8.03 |
Last Updated: August 20, 2025, 1:55 am
Below is a detailed analysis of the quarterly data for Uflex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,901.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,814.00 Cr. (Mar 2025) to 3,901.00 Cr., marking an increase of 87.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,447.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,404.00 Cr. (Mar 2025) to 3,447.00 Cr., marking an increase of 43.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 454.00 Cr.. The value appears strong and on an upward trend. It has increased from 410.00 Cr. (Mar 2025) to 454.00 Cr., marking an increase of 44.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 12.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 132.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 111.00 Cr..
- For Interest, as of Jun 2025, the value is 199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 184.00 Cr. (Mar 2025) to 199.00 Cr., marking an increase of 15.00 Cr..
- For Depreciation, as of Jun 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.00 Cr. (Mar 2025) to 187.00 Cr., marking an increase of 11.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 182.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 93.00 Cr..
- For Tax %, as of Jun 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 35.00%, marking an increase of 28.00%.
- For Net Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 111.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.03. The value appears to be declining and may need further review. It has decreased from 23.34 (Mar 2025) to 8.03, marking a decrease of 15.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,826 | 6,130 | 6,366 | 6,505 | 6,802 | 7,957 | 7,405 | 8,889 | 13,127 | 14,663 | 13,364 | 15,036 | 15,282 |
| Expenses | 5,137 | 5,395 | 5,561 | 5,630 | 5,921 | 6,969 | 6,324 | 7,085 | 10,956 | 12,913 | 11,976 | 13,344 | 13,577 |
| Operating Profit | 688 | 735 | 805 | 874 | 881 | 988 | 1,081 | 1,804 | 2,171 | 1,749 | 1,387 | 1,692 | 1,704 |
| OPM % | 12% | 12% | 13% | 13% | 13% | 12% | 15% | 20% | 17% | 12% | 10% | 11% | 11% |
| Other Income | 29 | 18 | 38 | 25 | 22 | 19 | 28 | 23 | 71 | -21 | -745 | -51 | 248 |
| Interest | 233 | 187 | 176 | 187 | 197 | 218 | 225 | 229 | 322 | 473 | 536 | 698 | 746 |
| Depreciation | 267 | 279 | 286 | 318 | 352 | 381 | 403 | 456 | 537 | 599 | 655 | 695 | 724 |
| Profit before tax | 217 | 286 | 382 | 395 | 354 | 409 | 481 | 1,142 | 1,382 | 656 | -549 | 248 | 482 |
| Tax % | 7% | 11% | 17% | 11% | 12% | 23% | 23% | 26% | 20% | 27% | 26% | 43% | |
| Net Profit | 202 | 256 | 317 | 351 | 312 | 315 | 371 | 844 | 1,099 | 481 | -691 | 142 | 390 |
| EPS in Rs | 27.92 | 35.28 | 43.46 | 48.26 | 43.00 | 43.46 | 51.21 | 116.73 | 152.09 | 66.57 | -95.69 | 19.71 | 54.05 |
| Dividend Payout % | 9% | 8% | 7% | 7% | 5% | 5% | 4% | 2% | 2% | 5% | -1% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 26.73% | 23.83% | 10.73% | -11.11% | 0.96% | 17.78% | 127.49% | 30.21% | -56.23% | -243.66% | 120.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -2.90% | -13.10% | -21.84% | 12.07% | 16.82% | 109.72% | -97.28% | -86.45% | -187.43% | 364.21% |
Uflex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -40% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | -11% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: July 25, 2025, 2:09 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 2,751 | 2,935 | 3,376 | 3,572 | 3,907 | 4,232 | 4,625 | 5,484 | 6,624 | 7,433 | 7,153 | 7,324 |
| Borrowings | 2,416 | 2,210 | 2,139 | 2,102 | 2,079 | 2,105 | 3,626 | 4,041 | 4,787 | 5,704 | 6,947 | 8,353 |
| Other Liabilities | 1,356 | 1,250 | 1,217 | 1,402 | 1,629 | 1,550 | 1,693 | 2,222 | 2,959 | 3,229 | 3,176 | 3,687 |
| Total Liabilities | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 |
| Fixed Assets | 3,378 | 3,240 | 3,255 | 3,394 | 3,766 | 3,759 | 3,808 | 5,032 | 6,417 | 7,786 | 8,223 | 8,739 |
| CWIP | 74 | 32 | 229 | 498 | 196 | 261 | 2,007 | 1,518 | 671 | 466 | 538 | 725 |
| Investments | 126 | 138 | 111 | 76 | 85 | 42 | 199 | 205 | 212 | 191 | 170 | 145 |
| Other Assets | 3,017 | 3,058 | 3,210 | 3,180 | 3,641 | 3,898 | 4,003 | 5,065 | 7,141 | 7,994 | 8,416 | 9,828 |
| Total Assets | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 |
Below is a detailed analysis of the balance sheet data for Uflex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 72.00 Cr..
- For Reserves, as of Mar 2025, the value is 7,324.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,153.00 Cr. (Mar 2024) to 7,324.00 Cr., marking an increase of 171.00 Cr..
- For Borrowings, as of Mar 2025, the value is 8,353.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 6,947.00 Cr. (Mar 2024) to 8,353.00 Cr., marking an increase of 1,406.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,687.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,176.00 Cr. (Mar 2024) to 3,687.00 Cr., marking an increase of 511.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 19,437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 8,739.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,223.00 Cr. (Mar 2024) to 8,739.00 Cr., marking an increase of 516.00 Cr..
- For CWIP, as of Mar 2025, the value is 725.00 Cr.. The value appears strong and on an upward trend. It has increased from 538.00 Cr. (Mar 2024) to 725.00 Cr., marking an increase of 187.00 Cr..
- For Investments, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 25.00 Cr..
- For Other Assets, as of Mar 2025, the value is 9,828.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,416.00 Cr. (Mar 2024) to 9,828.00 Cr., marking an increase of 1,412.00 Cr..
- For Total Assets, as of Mar 2025, the value is 19,437.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..
However, the Borrowings (8,353.00 Cr.) are higher than the Reserves (7,324.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 686.00 | 733.00 | 803.00 | 872.00 | 879.00 | 986.00 | -2.00 | -3.00 | -2.00 | -4.00 | -5.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 90 | 85 | 93 | 104 | 94 | 96 | 99 | 98 | 80 | 94 | 91 |
| Inventory Days | 60 | 63 | 64 | 70 | 72 | 63 | 73 | 89 | 86 | 91 | 84 | 100 |
| Days Payable | 86 | 72 | 80 | 98 | 108 | 79 | 90 | 104 | 92 | 85 | 90 | 90 |
| Cash Conversion Cycle | 69 | 80 | 68 | 64 | 68 | 78 | 79 | 83 | 92 | 87 | 88 | 101 |
| Working Capital Days | 22 | 23 | 23 | 22 | 36 | 32 | 31 | 45 | 56 | 41 | 36 | 20 |
| ROCE % | 9% | 9% | 10% | 10% | 9% | 10% | 10% | 15% | 17% | 10% | 6% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 40,093 | 0.18 | 2.4 | 40,093 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Diluted EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Cash EPS (Rs.) | 118.09 | -3.17 | 150.56 | 226.63 | 179.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Revenue From Operations / Share (Rs.) | 2082.23 | 1850.62 | 2030.49 | 1817.87 | 1231.21 |
| PBDIT / Share (Rs.) | 254.02 | 211.36 | 261.17 | 315.74 | 253.01 |
| PBIT / Share (Rs.) | 157.79 | 120.59 | 178.22 | 241.35 | 189.90 |
| PBT / Share (Rs.) | 36.51 | -74.24 | 91.88 | 191.42 | 158.17 |
| Net Profit / Share (Rs.) | 21.86 | -93.94 | 67.61 | 152.25 | 116.83 |
| NP After MI And SOA / Share (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| PBDIT Margin (%) | 12.19 | 11.42 | 12.86 | 17.36 | 20.54 |
| PBIT Margin (%) | 7.57 | 6.51 | 8.77 | 13.27 | 15.42 |
| PBT Margin (%) | 1.75 | -4.01 | 4.52 | 10.53 | 12.84 |
| Net Profit Margin (%) | 1.04 | -5.07 | 3.32 | 8.37 | 9.48 |
| NP After MI And SOA Margin (%) | 0.94 | -5.17 | 3.27 | 8.36 | 9.48 |
| Return on Networth / Equity (%) | 1.92 | -9.57 | 6.41 | 16.42 | 15.16 |
| Return on Capital Employeed (%) | 8.78 | 7.20 | 11.10 | 16.81 | 15.67 |
| Return On Assets (%) | 0.73 | -3.98 | 2.92 | 7.60 | 7.12 |
| Long Term Debt / Equity (X) | 0.65 | 0.57 | 0.46 | 0.45 | 0.50 |
| Total Debt / Equity (X) | 1.10 | 0.93 | 0.73 | 0.68 | 0.64 |
| Asset Turnover Ratio (%) | 0.81 | 0.79 | 0.63 | 0.64 | 0.62 |
| Current Ratio (X) | 1.31 | 1.46 | 1.56 | 1.64 | 1.55 |
| Quick Ratio (X) | 0.91 | 1.09 | 1.08 | 1.19 | 1.18 |
| Inventory Turnover Ratio (X) | 6.75 | 3.88 | 3.36 | 4.03 | 3.85 |
| Dividend Payout Ratio (NP) (%) | 5.07 | -3.13 | 4.50 | 1.64 | 1.71 |
| Dividend Payout Ratio (CP) (%) | 0.86 | -60.99 | 2.00 | 1.10 | 1.11 |
| Earning Retention Ratio (%) | 94.93 | 103.13 | 95.50 | 98.36 | 98.29 |
| Cash Earning Retention Ratio (%) | 99.14 | 160.99 | 98.00 | 98.90 | 98.89 |
| Interest Coverage Ratio (X) | 2.63 | 2.85 | 3.98 | 7.07 | 7.98 |
| Interest Coverage Ratio (Post Tax) (X) | 1.48 | 1.36 | 2.35 | 4.53 | 4.68 |
| Enterprise Value (Cr.) | 10561.28 | 8579.76 | 6834.46 | 8380.47 | 5629.29 |
| EV / Net Operating Revenue (X) | 0.70 | 0.64 | 0.46 | 0.63 | 0.63 |
| EV / EBITDA (X) | 5.76 | 5.62 | 3.62 | 3.68 | 3.08 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| Retention Ratios (%) | 94.92 | 103.13 | 95.49 | 98.35 | 98.28 |
| Price / BV (X) | 0.48 | 0.40 | 0.32 | 0.65 | 0.49 |
| Price / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| EarningsYield | 0.03 | -0.23 | 0.19 | 0.24 | 0.30 |
After reviewing the key financial ratios for Uflex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 118.09. This value is within the healthy range. It has increased from -3.17 (Mar 24) to 118.09, marking an increase of 121.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,082.23. It has increased from 1,850.62 (Mar 24) to 2,082.23, marking an increase of 231.61.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 254.02. This value is within the healthy range. It has increased from 211.36 (Mar 24) to 254.02, marking an increase of 42.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 157.79. This value is within the healthy range. It has increased from 120.59 (Mar 24) to 157.79, marking an increase of 37.20.
- For PBT / Share (Rs.), as of Mar 25, the value is 36.51. This value is within the healthy range. It has increased from -74.24 (Mar 24) to 36.51, marking an increase of 110.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.86. This value is within the healthy range. It has increased from -93.94 (Mar 24) to 21.86, marking an increase of 115.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 12.19, marking an increase of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 7.57, marking an increase of 1.06.
- For PBT Margin (%), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.75, marking an increase of 5.76.
- For Net Profit Margin (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 5. It has increased from -5.07 (Mar 24) to 1.04, marking an increase of 6.11.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 8. It has increased from -5.17 (Mar 24) to 0.94, marking an increase of 6.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 15. It has increased from -9.57 (Mar 24) to 1.92, marking an increase of 11.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.20 (Mar 24) to 8.78, marking an increase of 1.58.
- For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from -3.98 (Mar 24) to 0.73, marking an increase of 4.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.10. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 24) to 1.10, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.79 (Mar 24) to 0.81, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.31, marking a decrease of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 3.88 (Mar 24) to 6.75, marking an increase of 2.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 20. It has increased from -3.13 (Mar 24) to 5.07, marking an increase of 8.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 20. It has increased from -60.99 (Mar 24) to 0.86, marking an increase of 61.85.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.93. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.93, marking a decrease of 8.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.14. This value exceeds the healthy maximum of 70. It has decreased from 160.99 (Mar 24) to 99.14, marking a decrease of 61.85.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 24) to 2.63, marking a decrease of 0.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has increased from 1.36 (Mar 24) to 1.48, marking an increase of 0.12.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,561.28. It has increased from 8,579.76 (Mar 24) to 10,561.28, marking an increase of 1,981.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.70, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 5.76, marking an increase of 0.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 94.92. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.92, marking a decrease of 8.21.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 24) to 0.03, marking an increase of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uflex Ltd:
- Net Profit Margin: 1.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.78% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.92% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.48
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.4 (Industry average Stock P/E: 49.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.1
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 305, Third Floor, Bhanot Corner, New Delhi Delhi 110048 | secretarial@uflexltd.com http://www.uflexltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Chaturvedi | Chairman & Managing Director |
| Mr. Jeevaraj Gopal Pillai | Whole Time Director |
| Mrs. Sujit Kumar Varma | Independent Director |
| Mr. Ghyanendra Nath Bajpai | Independent Director |
| Mrs. Rashmi Verma | Independent Director |
| Mr. Paresh Nath Sharma | Independent Director |
FAQ
What is the intrinsic value of Uflex Ltd?
Uflex Ltd's intrinsic value (as of 28 November 2025) is 322.98 which is 35.66% lower the current market price of 502.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,622 Cr. market cap, FY2025-2026 high/low of 686/438, reserves of ₹7,324 Cr, and liabilities of 19,437 Cr.
What is the Market Cap of Uflex Ltd?
The Market Cap of Uflex Ltd is 3,622 Cr..
What is the current Stock Price of Uflex Ltd as on 28 November 2025?
The current stock price of Uflex Ltd as on 28 November 2025 is 502.
What is the High / Low of Uflex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uflex Ltd stocks is 686/438.
What is the Stock P/E of Uflex Ltd?
The Stock P/E of Uflex Ltd is 11.4.
What is the Book Value of Uflex Ltd?
The Book Value of Uflex Ltd is 1,070.
What is the Dividend Yield of Uflex Ltd?
The Dividend Yield of Uflex Ltd is 0.60 %.
What is the ROCE of Uflex Ltd?
The ROCE of Uflex Ltd is 7.75 %.
What is the ROE of Uflex Ltd?
The ROE of Uflex Ltd is 3.29 %.
What is the Face Value of Uflex Ltd?
The Face Value of Uflex Ltd is 10.0.